Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Neurosteroids as therapeutic leads in psychiatry.

Zorumski CF, Mennerick S.

JAMA Psychiatry. 2013 Jul;70(7):659-60. doi: 10.1001/jamapsychiatry.2013.245. No abstract available.

PMID:
23699915
2.

The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior.

Yadid G, Sudai E, Maayan R, Gispan I, Weizman A.

Neurosci Biobehav Rev. 2010 Nov;35(2):303-14. doi: 10.1016/j.neubiorev.2010.03.003. Epub 2010 Mar 12. Review.

PMID:
20227436
3.

The neurochemical basis of psychiatry.

Smythies JR.

Ala J Med Sci. 1980 Apr;17(2):159-61. No abstract available.

PMID:
6106434
4.

Amine precursor therapy: manipulation of brain amine activity with precursor amino acid.

Nakajima T.

Psychiatry Clin Neurosci. 1997 Oct;51(5):267-74. Review.

PMID:
9413872
5.

The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside.

Strous RD, Maayan R, Weizman A.

Eur Neuropsychopharmacol. 2006 Apr;16(3):155-69. Epub 2005 Oct 27. Review.

PMID:
16257183
6.

[Physiologic foundations and some perspectives of the further development of antiepileptic drugs].

Kozlovskiĭ VL.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(11 Pt 1):101-5. Russian. No abstract available.

PMID:
22611689
7.

What lies beneath.

[No authors listed]

Nature. 2014 Mar 20;507(7492):273. No abstract available.

PMID:
24654275
8.

Progesterone and its metabolites as therapeutic targets in psychiatric disorders.

Bristot G, Ascoli B, Gubert C, Panizzutti B, Kapczinski F, Rosa AR.

Expert Opin Ther Targets. 2014 Jun;18(6):679-90. doi: 10.1517/14728222.2014.897329. Epub 2014 Mar 21. Review.

PMID:
24654651
9.

Future viable models of psychiatry drug discovery in pharma.

Rizzo SJ, Edgerton JR, Hughes ZA, Brandon NJ.

J Biomol Screen. 2013 Jun;18(5):509-21. doi: 10.1177/1087057113475871. Epub 2013 Feb 7. Review.

PMID:
23392517
10.

GABAergic neuroactive steroids: a new frontier in bipolar disorders?

Carta MG, Bhat KM, Preti A.

Behav Brain Funct. 2012 Dec 19;8:61. doi: 10.1186/1744-9081-8-61. Review.

11.

Treatment of neuropsychiatric symptoms in dementia.

Friedman M.

Med Health R I. 2012 Jul;95(7):212-3. Review. No abstract available.

PMID:
22928233
12.

An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MD.

Janicak PG.

CNS Spectr. 2008 May;13(5):370-4. No abstract available.

PMID:
18543409
13.

Philosophical dimensions for psychiatry.

[No authors listed]

Aust N Z J Psychiatry. 2004 Jan-Feb;38(1-2):85. No abstract available.

PMID:
14731201
14.

A paradigm shift in brain research.

Carlsson A.

Science. 2001 Nov 2;294(5544):1021-4. Review.

PMID:
11691978
15.

[The role of interferon-alpha in regulation of nervous system functions].

Loseva EV, Loginova NA, Akmaev IG.

Usp Fiziol Nauk. 2008 Apr-Jun;39(2):32-46. Review. Russian.

PMID:
18540451
16.

Effects of dopamine and glutamate on synaptic plasticity: a computational modeling approach for drug abuse as comorbidity in mood disorders.

Qi Z, Kikuchi S, Tretter F, Voit EO.

Pharmacopsychiatry. 2011 May;44 Suppl 1:S62-75. doi: 10.1055/s-0031-1273707. Epub 2011 May 4.

PMID:
21544747
17.

[What's new in psychiatry? Advances in the area of psychochemistry].

Tapia-Ibargüengoytia R.

Gac Med Mex. 1981 May;117(5):173-9. Spanish. No abstract available.

PMID:
6118310
18.

Next-generation treatments for mental disorders.

Insel TR.

Sci Transl Med. 2012 Oct 10;4(155):155ps19. doi: 10.1126/scitranslmed.3004873.

PMID:
23052292
19.

Psychiatric treatment for great apes?

Brüne M, Brüne-Cohrs U, McGrew WC.

Science. 2004 Dec 17;306(5704):2039. No abstract available.

PMID:
15604390
20.

Neurosteroids in child and adolescent psychopathology.

Golubchik P, Lewis M, Maayan R, Sever J, Strous R, Weizman A.

Eur Neuropsychopharmacol. 2007 Feb;17(3):157-64. Epub 2006 Oct 31. Review.

PMID:
17079119
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk